Literature DB >> 25162667

Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Shonni J Silverberg1, Bart L Clarke, Munro Peacock, Francisco Bandeira, Stephanie Boutroy, Natalie E Cusano, David Dempster, E Michael Lewiecki, Jian-Min Liu, Salvatore Minisola, Lars Rejnmark, Barbara C Silva, Marcella D Walker, John P Bilezikian.   

Abstract

OBJECTIVE: This report summarizes data on traditional and nontraditional manifestations of primary hyperparathyroidism (PHPT) that have been published since the last International Workshop on PHPT. PARTICIPANTS: This subgroup was constituted by the Steering Committee to address key questions related to the presentation of PHPT. Consensus was established at a closed meeting of the Expert Panel that followed. EVIDENCE: Data from the 5-year period between 2008 and 2013 were presented and discussed to determine whether they support changes in recommendations for surgery or nonsurgical follow-up. CONSENSUS PROCESS: Questions were developed by the International Task Force on PHPT. A comprehensive literature search for relevant studies was undertaken. After extensive review and discussion, the subgroup came to agreement on what changes in the recommendations for surgery or nonsurgical follow-up of asymptomatic PHPT should be made to the Expert Panel.
CONCLUSIONS: 1) There are limited new data available on the natural history of asymptomatic PHPT. Although recognition of normocalcemic PHPT (normal serum calcium with elevated PTH concentrations; no secondary cause for hyperparathyroidism) is increasing, data on the clinical presentation and natural history of this phenotype are limited. 2) Although there are geographic differences in the predominant phenotypes of PHPT (symptomatic, asymptomatic, normocalcemic), they do not justify geography-specific management guidelines. 3) Recent data using newer, higher resolution imaging and analytic methods have revealed that in asymptomatic PHPT, both trabecular bone and cortical bone are affected. 4) Clinically silent nephrolithiasis and nephrocalcinosis can be detected by renal imaging and should be listed as a new criterion for surgery. 5) Current data do not support a cardiovascular evaluation or surgery for the purpose of improving cardiovascular markers, anatomical or functional abnormalities. 6) Some patients with mild PHPT have neuropsychological complaints and cognitive abnormalities, and some of these patients may benefit from surgical intervention. However, it is not possible at this time to predict which patients with neuropsychological complaints or cognitive issues will improve after successful parathyroid surgery.

Entities:  

Mesh:

Year:  2014        PMID: 25162667      PMCID: PMC5393491          DOI: 10.1210/jc.2014-1415

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  110 in total

1.  Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging.

Authors:  Cecilia Marini; Massimo Giusti; Riccardo Armonino; Giorgio Ghigliotti; GianPaolo Bezante; Lara Vera; Silvia Morbelli; Elena Pomposelli; Michela Massollo; Patrizia Gandolfo; Francesco Minuto; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-04       Impact factor: 9.236

2.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

3.  Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.

Authors:  Didier Hans; Andrew L Goertzen; Marc-Antoine Krieg; William D Leslie
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

4.  Aortic valve calcification in mild primary hyperparathyroidism.

Authors:  Shinichi Iwata; Marcella Donovan Walker; Marco R Di Tullio; Eiichi Hyodo; Zhezhen Jin; Rui Liu; Ralph L Sacco; Shunichi Homma; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

5.  Depression in primary hyperparathyroidism: prevalence and benefit of surgery.

Authors:  Rachel P Espiritu; Ann E Kearns; Kristin S Vickers; Clive Grant; Euijung Ryu; Robert A Wermers
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

6.  Effect of gender and geographic location on the expression of primary hyperparathyroidism.

Authors:  F De Lucia; S Minisola; E Romagnoli; J Pepe; C Cipriani; A Scillitani; N Parikh; D S Rao
Journal:  J Endocrinol Invest       Date:  2012-06-18       Impact factor: 4.256

7.  Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.

Authors:  Ego Seeman; Pierre D Delmas; David A Hanley; Deborah Sellmeyer; Angela M Cheung; Elizabeth Shane; Ann Kearns; Thierry Thomas; Steven K Boyd; Stephanie Boutroy; Cesar Bogado; Sharmila Majumdar; Michelle Fan; Cesar Libanati; Jose Zanchetta
Journal:  J Bone Miner Res       Date:  2010-08       Impact factor: 6.741

8.  Trabecular bone score (TBS)--a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism.

Authors:  Barbara Campolina Silva; Stephanie Boutroy; Chiyuan Zhang; Donald Jay McMahon; Bin Zhou; Ji Wang; Julia Udesky; Serge Cremers; Marta Sarquis; Xiang-Dong Edward Guo; Didier Hans; John Paul Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2013-03-22       Impact factor: 5.958

9.  Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Authors:  Jens Bollerslev; Svante Jansson; Charlotte L Mollerup; Jörgen Nordenström; Eva Lundgren; Ove Tørring; Jan-Erik Varhaug; Marek Baranowski; Sylvi Aanderud; Celina Franco; Bo Freyschuss; Gunhild A Isaksen; Thor Ueland; Thord Rosen
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

10.  Systematic review of primary hyperparathyroidism in India: the past, present, and the future trends.

Authors:  P V Pradeep; B Jayashree; Anjali Mishra; S K Mishra
Journal:  Int J Endocrinol       Date:  2011-05-26       Impact factor: 3.257

View more
  78 in total

1.  Compliance with recommendations on surgery for primary hyperparathyroidism-from guidelines to real practice: results from an Iberian survey.

Authors:  Jesús Villar-Del-Moral; João Capela-Costa; Antonio Jiménez-García; Antonio Sitges-Serra; Daniel Casanova-Rituerto; José Rocha; Juan Manuel Martos-Martínez; Aitor de la Quintana-Basarrate; Jorge Rosa-Santos; Xavier Guirao-Garriga; José Miguel Bravo-de-Lifante; Óscar Vidal-Pérez; Antonio Moral-Duarte; José Polónia
Journal:  Langenbecks Arch Surg       Date:  2015-12-19       Impact factor: 3.445

2.  Occult urolithiasis in asymptomatic primary hyperparathyroidism.

Authors:  Yu-Kwang Donovan Tay; Minghao Liu; Leonardo Bandeira; Mariana Bucovsky; James A Lee; Shonni J Silverberg; Marcella D Walker
Journal:  Endocr Res       Date:  2018-02-05       Impact factor: 1.720

3.  Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology.

Authors:  Cristiana Cipriani; Federica Biamonte; Aline G Costa; Chiyuan Zhang; Piergianni Biondi; Daniele Diacinti; Jessica Pepe; Sara Piemonte; Alfredo Scillitani; Salvatore Minisola; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2015-02-03       Impact factor: 5.958

4.  Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

Authors:  F Saponaro; F Cetani; L Mazoni; M Apicella; M Di Giulio; F Carlucci; M Scalese; E Pardi; S Borsari; J P Bilezikian; C Marcocci
Journal:  J Endocrinol Invest       Date:  2019-12-23       Impact factor: 4.256

Review 5.  Hyperparathyroidism and Bone Health.

Authors:  Francisco Bandeira; Sara Cassibba
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

6.  MR appearance of parathyroid adenomas at 3 T in patients with primary hyperparathyroidism: what radiologists need to know for pre-operative localization.

Authors:  B Sacconi; R Argirò; Daniele Diacinti; A Iannarelli; M Bezzi; C Cipriani; D Pisani; V Cipolla; C De Felice; S Minisola; C Catalano
Journal:  Eur Radiol       Date:  2015-05-31       Impact factor: 5.315

7.  Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

Authors:  C Marcocci; M L Brandi; A Scillitani; S Corbetta; A Faggiano; L Gianotti; S Migliaccio; S Minisola
Journal:  J Endocrinol Invest       Date:  2015-03-28       Impact factor: 4.256

8.  Classic Primary Hyperparathyroidism Versus Normocalcemic and Normohormonal Variants: Do They Really Differ?

Authors:  Andreas Kiriakopoulos; Athanasios Petralias; Dimitrios Linos
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

9.  Attitude of the surgical approach in hyperparathyroidism: A retrospective study.

Authors:  Claudiu Eduard Nistor; Camelia Stanciu-Găvan; Florina Vasilescu; Adrian Vasile Dumitru; Adrian Ciuche
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

Review 10.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.